Literature DB >> 12761287

Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.

Yoshimitsu Takahashi1, Akio Toh-E, Yoshiko Kikuchi.   

Abstract

SUMO/Smt3, a ubiquitin-like modifier, is known to conjugate other proteins and modulate their functions in various processes. Recently, Ull1/Siz1 was discovered as a novel PIAS-type E3 required for septin sumoylation in yeast. We demonstrate here that the second PIAS-type Nfi1/Siz2 is also a SUMO ligase. It interacted with Smt3, SUMO/Smt3 conjugating enzyme Ubc9 and a septin component Cdc3 in the two-hybrid system. The region containing the RING-like domain of Nfi1/Siz2 bound directly to Ubc9 and Cdc3, but not to Smt3. Nfi1/Siz2 stimulated Smt3 conjugation to Cdc3 in vitro. In this in vitro system, Smt3 formed polymeric chains in the presence of higher concentrations of E1 and E2 enzymes. When the lysine(15) residue of Smt3 was substituted with arginine, Smt3 chain-polymerization was abolished. Using this polysumoylation-deficient mutant Smt3, we found that Cdc3 and Nfi1/Siz2 were modified with Smt3 at multiple sites. Finally we found that the C-terminal truncated form of Ull1/Siz1 was mis-localized in vivo, but retained its SUMO ligase activity in vitro. We discuss the regulation of these SUMO ligases in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761287     DOI: 10.1093/jb/mvg054

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  32 in total

1.  Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.

Authors:  Hyunju Ryu; Yoshiaki Azuma
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

2.  Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage.

Authors:  Emily A Andrews; Jan Palecek; John Sergeant; Elaine Taylor; Alan R Lehmann; Felicity Z Watts
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

3.  SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.

Authors:  Motomasa Ihara; Hideki Yamamoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  In vivo modeling of polysumoylation uncovers targeting of Topoisomerase II to the nucleolus via optimal level of SUMO modification.

Authors:  Yoshimitsu Takahashi; Alexander Strunnikov
Journal:  Chromosoma       Date:  2007-11-29       Impact factor: 4.316

5.  SIZ1/SIZ2 control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II.

Authors:  Yoshimitsu Takahashi; Vladimir Yong-Gonzalez; Yoshiko Kikuchi; Alexander Strunnikov
Journal:  Genetics       Date:  2005-10-03       Impact factor: 4.562

6.  SUMOylation regulates the homologous to E6-AP carboxyl terminus (HECT) ubiquitin ligase Rsp5p.

Authors:  Tatiana Vladislavovna Novoselova; Ruth-Sarah Rose; Helen Margaret Marks; James Andrew Sullivan
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

7.  The jmjN and jmjC domains of the yeast zinc finger protein Gis1 interact with 19 proteins involved in transcription, sumoylation and DNA repair.

Authors:  Susanna Tronnersjö; Christine Hanefalk; Darius Balciunas; Guo-Zhen Hu; Niklas Nordberg; Eva Murén; Hans Ronne
Journal:  Mol Genet Genomics       Date:  2006-10-17       Impact factor: 3.291

8.  SUMO Protease SMT7 Modulates Ribosomal Protein L30 and Regulates Cell-Size Checkpoint Function.

Authors:  Yen-Ling Lin; Chin-Lin Chung; Ming-Hui Chen; Chun-Han Chen; Su-Chiung Fang
Journal:  Plant Cell       Date:  2020-02-14       Impact factor: 11.277

9.  Localization of recombination proteins and Srs2 reveals anti-recombinase function in vivo.

Authors:  Rebecca C Burgess; Michael Lisby; Veronika Altmannova; Lumir Krejci; Patrick Sung; Rodney Rothstein
Journal:  J Cell Biol       Date:  2009-06-08       Impact factor: 10.539

10.  SUMO chain formation is required for response to replication arrest in S. pombe.

Authors:  Andrew Skilton; Jenny C Y Ho; Brenda Mercer; Emily Outwin; Felicity Z Watts
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.